FUBROMEGAN (Fubromeganum). 1-Metil-3- dietilaminopropilovogo ether 5 - bromine furan-2- yodmetilat carboxylic acid.

     Yellow powder. It soluble in water, soluble in alcohol.

     Provides peripheral M-holinoliticheskoe (atropinopodobnoe) and moderate n-holinoliticheskoe (ganglioblokiruyuschee) action, as well as the direct effect on the skin smooth musculature.

     Apply with gastric ulcer disease and stomach cancer, bronchial asthma, liver and renal colic, as well as cramps in the coronary vessels.

     Assign inside (to food), from 0.03 g (30 mg) to pick up 2 to 3 times a day. If necessary, increase the dose to 60-90 mg per reception. The course of treatment is continuing on average 2 to 3 weeks.

     Possible side effects: drought in the mouth, headache, sometimes pain in the heart. In these cases, reduce the dose or stop receiving the drug.

     The product contraindications patients suffering from glaucoma, as well as pregnancy.

     Method of issuance: powder; Tablets (white with a slightly yellowish tinge) to 0.0 g Z in the package of 50 pieces.

     Storage: List B. In a dry, sheltered from the world scene.

Materials allowed to copy only with the active hyperlink to the handbook of medicines